ASX:CBLHealth Care Equipment & ServicesHealth Care Equipment
Control Bionics Ltd
$0.069
Day Range
$0.069 – $0.069
52 Week Range
$0.032 – $0.095
Volume
8.00K
Avg Volume (10D)
192.34K
Market Cap
$30.73M
Price Chart
Market Statistics
Open$0.069
Previous Close$0.069
Day High$0.069
Day Low$0.069
52 Week High$0.095
52 Week Low$0.032
Valuation
Market Cap30.73M
Shares Outstanding445.32M
Price to Book3.68
Trading Activity
Volume8.00K
Value Traded552.00
Bid$0.067 × 200,000
Ask$0.069 × 54,000
Performance
1 Day-1.43%
5 Day4.55%
13 Week6.15%
52 Week56.59%
YTD13.11%
Technical Indicators
RSI (14)49.27
50-Day SMA$0.073
200-Day SMA$0.062
Latest News
Technology
Control Bionics Secures FDA Registration for NeuroStrip Wearable Platform
Control Bionics wins FDA registration for NeuroStrip, boosting regulatory credibility and accelerating growth in Performance, Rehab, and Research.
Technology
Control Bionics Bolsters European Expansion with German Reimbursement for NeuroNode
Control Bionics (ASX: CBL) secures German reimbursement for NeuroNode, fueling Europe wholesale push and distributor ramp-up amid funding risks.
Technology
Control Bionics Signs US JV for iOS Speech Devices with NextLevel Assistive Technology
Control Bionics inks exclusive US JV with NextLevel for iOS speech devices, FDA Manufacturer of Record; aims 1,000–1,500 units/year in a USD 100–150m market.
Technology
Control Bionics Integrates Apple Brain–Computer Interface to Enhance Accessibility and Independence
Control Bionics (ASX: CBL) has implemented Apple’s new Brain–Computer Interface protocol across its product range, a major step forward in assistive communication technology for people living with severe speech and physical impairments.